<div style="border: 1px solid #000001; padding: 2px, margin-bottom: 5px;">
    <b>WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY</b>
    <br>
    <b>
        <ul>
            <li>Serious harm or death could result if administered intravenously.</li> 
            <li>SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emobli, if administered intravenously.</li>
        </ul>
    </b>
 </div>
        <br>
        <b>IMPORTANT SAFETY INFORMATION</b>
        <br>
        <br>
            Prescription use of this product is limited under the Drug Addiction Treatment Act.
        <br>
        <br>
        <b>CONTRAINDICATIONS</b>
        <br>
        <br>
            SUBLOCADE should not be administered to patients who have been shown to be hypersensitive to buprenorphine or any component of the ATRIGEL<sup>&reg</sup> delivery system.
        <br>
        <br>
      
        <b>Please  <a href="https://www.sublocade.com/Content/pdf/prescribing-information.pdf" target="_blank>">click here </a>to full, Prescribing Information including BOXED WARNING</b>
